Related Experiment Videos
Route-dependent immunomodulation: local stimulation by a surfactant and systemic stimulation by a polyanion
International Archives of Allergy and Applied Immunology
|January 1, 1986
Summary
Dimethyldioctadecylammonium bromide (DDA) and dextran sulfate (DXS) show distinct immunomodulatory activities. DXS enhances systemic immune responses, while DDA
Area of Science:
- Immunology
- Pharmacology
Background:
- Synthetic adjuvants like dimethyldioctadecylammonium bromide (DDA) and dextran sulfate (DXS) modulate immune responses.
- Understanding adjuvant properties is crucial for vaccine development and immunotherapy.
Purpose of the Study:
- To investigate the immunomodulatory activity of DDA and DXS.
- To determine the influence of injection route and timing on adjuvant efficacy.
- To compare the systemic versus localized effects of DDA and DXS.
Main Methods:
- Mice were immunized with sheep red blood cells (SRBC) and either DDA or DXS.
- Humoral response was quantified by measuring plaque-forming cells (PFC) in the spleen.
- Adjuvant and antigen administration varied in route (intraperitoneal/intravenous) and timing.
Main Results:
- Both DDA and DXS stimulated anti-SRBC response when co-administered via the same route.
- DXS enhanced humoral response when administered via different routes, unlike DDA.
- Prior intraperitoneal administration of either adjuvant suppressed responses, but this effect was localized to the peritoneal cavity.
Conclusions:
- DDA and DXS exhibit different immunostimulating properties.
- DXS induces a systemic immunoresponsive state, whereas DDA's effect is route-dependent.
- The immunosuppressive effect of prior adjuvant injection is compartment-specific.